Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Vaccine

Nearly 1,300 cases of new Covid variant found in UK with positive tests doubling in a month

"So far there is not enough evidence to draw conclusions about transmissibility, severity or vaccine effectiveness."

Manchester Evening News

Man, 96, dies after allergic reaction to Covid-19 vaccine, inquest hears

An inquest report from the Rutland and North Leicestershire Coroner's Office says resuscitation was attempted at the scene , but he was confirmed dead on arrival at hospital by medical staff

Daily Mirror

Trial results of US Army ‘moon shot’ Covid vaccine that ‘protects against all variants’ expected

Experts say the new jab could be the ‘first universal vaccine against Covid-19’

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Covid Ireland: Who needs a second booster? All you need to know as vaccine rollout continues

The situation has improved massively in the country so far in 2022, though the virus is not completely eliminated.

Irish Mirror

New push to vaccinate school kids this term

The Centre for Covid-19 Situation Administration (CCSA) has held talks with the Ministry of Education on distributing vaccines for school kids, ahead of the new term which begins next month.

Bangkok Post

NSW finalises COVID school return plans

After scrapping home isolation and announcing tweaks to vaccine mandates the NSW government has announced what the return to school will look like.

AAP

How many California lives were saved by COVID-19 vaccines? Scientists have an answer

LOS ANGELES — The arrival of the first COVID-19 vaccines in December 2020 marked the start of a new, safer phase of the pandemic.

Los Angeles Times

Read news from The Economist, FT, and more,
with one subscription

COVID rules are winding back, but some Australians are still locking down

Cities around the country are again heaving with life, but many of the approximately 500,000 Australians who are severely immunocompromised are left fearing for their health.

ABC News

Lessons from COVAX could help vaccine equity

COVAX was supposed to be the elixir for vaccine inequality - it wasn’t. However, lessons can be taken from previous global experiences to help make progress, writes Putri Widi Saraswati.

Newsroom.co.nz

If You Invested $1,000 In BioNTech Stock At Its Pandemic Low, Here's How Much You'd Have Now

Investors who bought stocks during the COVID-19 market crash in 2020 have generally experienced some big gains in the past two years. But there is no question some big-name stocks performed better than others since the pandemic bottom.

Benzinga

Trial results of 'moon shot' Covid-19 vaccine that 'protects against all variants' expected in coming days

Results of the trial on the single-shot jab are expected in the coming days.

Dublin Live

Govt receives 200k Covovax dose lift

The Ministry of Public Health will distribute 200,000 coronavirus protein-based vaccine doses donated by India and its partners to state-owned hospitals across Thailand with the target of inoculating those unvaccinated people.

Bangkok Post

Waiting longer between Covid jabs 'could generate up to nine times more antibodies'

Antibody levels in blood samples taken from almost 6,000 healthcare workers from across the UK were measured

Wales Online

CPS employee vaccine mandate reinstated by Illinois appellate court

The downstate court’s decision represents a win for CPS and lets officials resume enforcing their vaccine mandate while a lawsuit challenging the policy plays out.

Chicago Sun-Times

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Celsion's Formulated DNA Plasmid COVID-19 Vaccine Candidate Shows Activity Against Two Strains

Celsion Corporation (NASDAQ:CLSN) has presented its PLACCINE platform technology at the World Vaccine Congress. "PLACCINE is demonstrating the potential to be a powerful platform that provides for rapid design capability for targeting two or more different variants of a single virus in one vaccine," said Dr. Khursheed Anwer, Chief Science Officer at Celsion.…

Dublin Live

Covid-19 Ireland: People aged 65 and over eligible for second booster vaccine

The online portal to register for a second booster opens today

Benzinga

If You Invested $1,000 In Pfizer Stock At Its Pandemic Low, Here's How Much You'd Have Now

The Hindu

Government panel recommends emergency use authorisation for Corbevax for 5-11 age group

The Subject Expert Committee has also recommended the grant of EUA to Cadila for their ZyCoV-D vaccine

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - AU

NSW employers can still require staff Covid jabs, despite end of most mandates, say workplace lawyers

Vaccine mandates will remain in place for now in Victoria as authorities work with individual industries

The Independent UK

More funding needed for rollout of highly effective malaria vaccine, Oxford chief warns

‘It seems extraordinary after the worst pandemic we’ve had in a century ... we can’t find the money to get Africa out of the horrendous mortality that it’s been suffering from malaria,’ says Professor Adrian Hill

Irish Mirror

‘Moon shot’ Covid vaccine that works against all variants hailed by Prof Luke O’Neill

Test results on animals have been 'impressive', according to the professor of biochemistry at Trinity College, who expects data from the phase one trial on humans to be published 'any day now'

Benzinga

The Daily Biotech Pulse: Ampio Falls On Knee Osteoarthritis Trial Update, AstraZeneca's COVID-19 Antibody Data, CureVac-GSK's Bivalent COVID-19 Vaccine Data

Here's a roundup of top developments in the biotech space over the last 24 hours.

The Independent UK

Third Covid-19 vaccine dose offers ‘prolonged immune response’ – UK-wide study

The study compared immune responses to seven vaccines used as a booster 28 days after two initial doses.

Benzinga

Codiak BioSciences's Pan Beta-Coronavirus Vaccine Shows Encouraging Action In Animal Studies

Codiak BioSciences Inc (NASDAQ:CDAK) announced new preclinical data from its pan beta-coronavirus vaccine program. The data demonstrate the potential for the vaccine candidate to induce cross-neutralizing antibody protection against multiple strains and an antigen-specific & immune response against structurally conserved regions of various coronavirus variants. Preclinical data showed a durable antibody response lasting…

The Guardian - UK

Globalisation is not working – in an age of insecurity, we need more local solutions

From the supply-chain crisis to Covid vaccines, the past couple of years have brought home the benefits of self-sufficiency, says the Guardian’s economics editor, Larry Elliott

1 … 295 296 297 298

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Intellectual Property

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.